Invesco’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-67,734
| Closed | -$776K | – | 4013 |
|
|
2020
Q4 | $776K | Buy |
67,734
+822
| +1% | +$9.37K | ﹤0.01% | 3052 |
|
|
2020
Q3 | $462K | Sell |
66,912
-1,933
| -3% | -$12.7K | ﹤0.01% | 3152 |
|
|
2020
Q2 | $449K | Sell |
68,845
-1,481
| -2% | -$9.56K | ﹤0.01% | 3179 |
|
|
2020
Q1 | $465K | Buy |
70,326
+24,073
| +52% | +$210K | ﹤0.01% | 3083 |
|
|
2019
Q4 | $480K | Buy |
46,253
+6,481
| +16% | +$55.4K | ﹤0.01% | 3265 |
|
|
2019
Q3 | $251K | Buy |
39,772
+2,339
| +6% | +$17.4K | ﹤0.01% | 3486 |
|
|
2019
Q2 | $279K | Sell |
37,433
-8,379
| -18% | -$55.3K | ﹤0.01% | 3520 |
|
|
2019
Q1 | $281K | Sell |
45,812
-13,161
| -22% | -$152K | ﹤0.01% | 3510 |
|
|
2018
Q4 | $679K | Sell |
58,973
-3,074
| -5% | -$52.4K | ﹤0.01% | 3154 |
|
|
2018
Q3 | $1.34M | Sell |
62,047
-65,052
| -51% | -$1.23M | ﹤0.01% | 2992 |
|
|
2018
Q2 | $2M | Buy |
127,099
+108,220
| +573% | +$1.7M | ﹤0.01% | 2751 |
|
|
2018
Q1 | $356K | Buy |
18,879
+2,967
| +19% | +$58.5K | ﹤0.01% | 3453 |
|
|
2017
Q4 | $277K | Buy |
15,912
+208
| +1% | +$2.87K | ﹤0.01% | 3464 |
|
|
2017
Q3 | $235K | Buy |
15,704
+980
| +7% | +$15.4K | ﹤0.01% | 3519 |
|
|
2017
Q2 | $273K | Buy |
14,724
+21
| +0.1% | +$365 | ﹤0.01% | 3513 |
|
|
2017
Q1 | $248K | Buy |
+14,703
| New | +$293K | ﹤0.01% | 3553 |
|
|
2016
Q4 | – | Sell |
-27,597
| Closed | -$504K | – | 3727 |
|
|
2016
Q3 | $504K | Buy |
+27,597
| New | +$622K | ﹤0.01% | 3268 |
|
Invesco's ARA Position: Q1 2021 in Review
Invesco sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 67,734 shares — an estimated $776K sold.
Invesco first reported a position in ARA in Q3 2016 and held it in 17 quarters. The position peaked at $2M in Q2 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Invesco reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Invesco sold 67,734 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $776K.
- Invesco first reported a position in American Renal Associates Holdings, Inc in Q3 2016 and held it in 17 quarters.
- Invesco's American Renal Associates Holdings, Inc position peaked at $2M in Q2 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Invesco's 13F filing for Q1 2021, filed 17 May 2021.